Navigating the implementation gap for Trastuzumab's journey from health insurance to patient access: a preliminary study in a hospital in China
{{output}}
Background: Trastuzumab, a monoclonal antibody for breast cancer, faces global accessibility challenges, primarily due to high costs. This study examines how changes in medical insurance policies and price adjustments influence T... ...
